We are proud to announce that AGILeBiotics has been awarded the Lead Development Voucher by the Netherlands Antibiotic Development Platform (NADP). The total amount of €50.000 will be allocated to the pre-clinical R&D activities. With this financial support we will evaluate the in vivo efficacy of our antibiotic candidates in a clinically relevant animal model […]
Menu
